Therapeutic Considerations in Metastatic HER2+ Breast Cancer: Part 2

This publication includes a summary of data on recent therapeutic advances in treating metastatic HER2-positive breast cancer that was presented during a series of 4 live regional broadcasts across the United States (Florida, Maryland, Massachusetts, New York, North Carolina, Pennsylvania, Virginia, and Washington, DC). Medical oncologists specializing in the treatment of breast cancer across those regions provide key insights on factors that influence planning and treatment selection.